Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 729Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3MERCK SHARP DOHME

02 22MSD SUB MERCK

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LAMIVUDINE; RALTEGRAVIR POTASSIUM

US Patent Number : 7754731

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206510

Patent Use Code : U-1663

Delist Requested :

Patent Use Description : TREATMENT OF HIV-1 INF...

Patent Expiration Date : 2029-03-11

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LAMIVUDINE; RALTEGRAVIR POTASSIUM

US Patent Number : 7754731*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 206510

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-11

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

LAMIVUDINE; RALTEGRAVIR POTASSIUM

US Patent Number : 7169780*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 206510

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-04-03

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 7754731

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205786

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2029-03-11

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 7754731

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22145

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2029-03-11

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 7754731

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22145

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2029-03-11

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 8771733

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203045

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2030-06-02

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 8852632

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22145

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2028-01-28

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 8771733

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22145

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2030-06-02

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

RALTEGRAVIR POTASSIUM

US Patent Number : 8771733

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22145

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2030-06-02

blank